AmitArunKulkarniMD

PubMed

• Trajectories of Health Care Contact Days for Patients With Stage IV Non-Small Cell Lung Cancer.
  Paul Nguyen, Danielle Kain, Andrew G Robinson, David H Johnson, Christopher M Booth, Timothy P Hanna, Arjun Gupta, Amit A Kulkarni, Carolyn J Presley, Anne H Blaes, Ga...> ;JAMA Network Open. 2024 Apr 1
• Association of antibiotic exposure with residual cancer burden in HER2-negative early stage breast cancer.
  Patricia I Jewett, Laura Van 't Veer, Gillian Hirst, , Amit A Kulkarni, Aditya Jain, Nidhi Desai, Douglas Yee, Anne H Blaes> ;NPJ Breast Cancer. 2024 Mar 26
• Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study.
  Gayathri Nagaraj, Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M Kuderer, David M Aboulafia, Jared D Acoba, Joy Awosika, Ziad Bakouny, Nicole B Balmaceda, Ting ...> ;Elife. 2023 Oct 17
• 2 citations
  Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.
  Gayathri Nagaraj, Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M Kuderer, David M Aboulafia, Jared D Acoba, Joy Awosika, Ziad Bakouny, Nicole B Balmaceda, Ting ...> ;Medrxiv. 2023 Mar 10
• 20 citations
  Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
  Vikas, P., Bakouny, Z., Labaki, C., Grover, P., Awosika, J., Gulati, S., Hsu, C., Alimohamed, S., Bashir, B., Berg, S., Bilen, M., Bowles, D., Castellano, C., Desai, A...> ;JAMA Oncology. 2023 Jan 1
• 1 citations
  Nonlinear association between body mass index and overall survival in advanced NSCLC patients treated with immune checkpoint blockade.
  Aditya Jain, Shijia Zhang, Ryan M Shanley, Naomi Fujioka, Robert A Kratzke, Manish R Patel, Amit A Kulkarni> ;Cancer Immunology, Immunotherapy. 2023 May 1
• 3 citations
  Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study.
  Wagner, M., Hennessy, C., Beeghly, A., French, B., Shah, D., Croessmann, S., Vilar-Compte, D., Ruiz-Garcia, E., Ingham, M., Schwartz, G., Painter, C., Chugh, R., Feche...> ;Cancers. 2022 Sep 5
• Resistance to EGFR Tyrosine Kinase Inhibitor Therapy in Non-Small-Cell Lung Cancer via Newly Acquired Targetable Oncogenic Driver Alterations With an Emphasis on: Case...
  Nicholas P Giustini, Sandip Pravin Patel, Nathaniel J Myall, José Fernando do Prado Moura, Amit Kulkarni, Richard C Chao, Heather Wakelee, Lyudmila Bazhenova> ;JCO Precision Oncology. 2022 Aug 1
• 2 citations
  Exceptional response to afatinib in a patient with persistent G719A-mutant NSCLC.
  Amit A Kulkarni, Naomi Fujioka, Lucia Reinhardt, Manish R Patel, Robert A Kratzke> ;Lung Cancer Management. 2022 Mar 1
• A Turning Point for Mesothelioma Therapy.
  Amit Kulkarni, Robert A. Kratzke> ;JCO Oncology Practice. 2021 Oct 15
• 11 citations
  Risk for stroke and myocardial infarction with abiraterone versus enzalutamide in metastatic prostate cancer patients
  Amit Kulkarni, N. Rubin, A. Tholkes, Surbhi Shah, Charles J. Ryan, Pamela L. Lutsey, Anna E. Prizment, A. Rao> ;ESMO Open. 2021 Oct 1
• 17 citations
  The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19.
  Ang Li, Nicole M. Kuderer, Chih-Yuan Hsu, Yu Shyr, Jeremy L. Warner, Dimpy P. Shah, Vaibhav Kumar, Surbhi Shah, Amit Kulkarni, Julie Fu, Shuchi Gulati, Rebecca L. Zon,...> ;Journal of Thrombosis and Haemostasis. 2021 Jul 14
• 12 citations
  Real-World Outcomes and Clinical Predictors of Immune Checkpoint Inhibitor Monotherapy in Advanced Lung Cancer.
  Shijia Zhang, Daniel F. Pease, Amit Kulkarni, Ryan Shanley, Beibei Xu, Shilvi P Joshi, Manish R. Patel> ;Clinical Medicine Insights. Oncology. 2021 Mar 31
• 9 citations
  Is It Time to Implement Adjuvant Targeted Therapy in EGFR-Mutant Non–Small-Cell Lung Cancer?
  Amit Kulkarni, Abdul Rafeh Naqash, Sonam Puri, Rodrigo Dienstmann> ;JCO Precision Oncology. 2021 Feb 17
• 18 citations
  Comparative analysis of antibiotic exposure association with clinical outcomes of chemotherapy versus immunotherapy across three tumour types.
  Amit Kulkarni, Maryam Ebadi, Shijia Zhang, Mohamad Aghaie Meybodi, Alaa M. Ali, Todd E. DeFor, Ryan Shanley, Daniel J. Weisdorf, Charles J. Ryan, Sumithira Vasu, Armin...> ;ESMO Open. 2020 Sep 1
• 2 citations
  Clinical Trial End Points in Severe COVID-19.
  Aakash Desai, Amit Kulkarni, S. Vincent Rajkumar, Bishal Gyawali> ;Mayo Clinic Proceedings. 2020 Jun 6
• 23 citations
  Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis.
  Shijia Zhang, Amit Kulkarni, Beibei Xu, Haitao Chu, Taxiarchis Kourelis, Ronald S. Go, Michael L. Wang, Veronika Bachanova, Yucai Wang> ;Blood Cancer Journal. 2020 Mar 6
• Join now to see all